DHT Holdings Inc. vs Medtronic PLC — how do they compare? DHT Holdings Inc. trades at $24.9 (market cap $4.02B), while Medtronic PLC trades at $87.92 (market cap $112.24B). The key difference: Medtronic PLC is far larger — about 27.9× DHT Holdings Inc.'s market cap, and DHT Holdings Inc. pays the higher dividend (19.57%). Which is the better fit depends on your goals — on Pluang, investors hold DHT Holdings Inc. for 0 Days and Medtronic PLC for 63 Days on average.
| DHT | MDT | |
|---|---|---|
Market Cap | $4.02B | $112.24B |
Volume | 5,493,801 | 105,663,236 |
Sector | Industrials | Health |
52-Week High | $24.93 | $105.35 |
52-Week Low | $11.20 | $73.75 |
Typical Hold Time | 0 Days | 63 Days |
Enterprise Value | $4.29B | $131.58B |
Dividend Yield | 19.57% | 3.28% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Medtronic (MDT) trades at $85.51, down 1.81% on the day, showing bearish technical signals despite strong fundamental performance. The company has beaten earnings estimates for three consecutive quarters with Q3 2026 results pending, while maintaining robust profitability margins of 65% gross and 14% net. Recent news highlights the company's 49-year dividend growth streak and new product approvals, though technical indicators show selling pressure with the stock trading near support at $85.
MDT presents a compelling value opportunity with a 3.2% dividend yield and 14% upside to the $97.80 consensus target, though near-term technical weakness and increasing debt levels warrant caution. The company's consistent earnings beats and medical device market leadership support long-term growth, while regulatory approvals for new systems provide catalysts.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
DHT Holdings operates a fleet of crude oil tankers that trade on international routes. Its fleet consists of very large crude carriers, or VLCCs.
Read more on DHT →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →